Whitsett J A, Noguchi A, Moore J J
Semin Perinatol. 1982 Apr;6(2):125-41.
Clearly a number of hormonal, pathologic, and maturation factors alter alpha- and beta-adrenergic receptors during development. Ontogenic changes in these receptors appear to be organ- and species-specific, occurring at distinct times during organ maturation. Developmental changes in adrenergic receptors are probably the result of a number of homologous and heterologous regulatory mechanisms. These are likely to include the effects of differentiation and aging themselves, and in fact some of the most dramatic changes in adrenergic receptor number and function occur during development. These changes are likely important to the adaptation of the developing infant and knowledge of their appearance, regulation, and function will be useful in predicting therapeutic or toxic effects of these treatments on the developing fetus and infant when exposed to adrenergic agonists or antagonists.
显然,在发育过程中,许多激素、病理和成熟因素会改变α和β肾上腺素能受体。这些受体的个体发生变化似乎具有器官和物种特异性,在器官成熟的不同时间出现。肾上腺素能受体的发育变化可能是多种同源和异源调节机制的结果。这些可能包括分化和衰老本身的影响,事实上,肾上腺素能受体数量和功能的一些最显著变化发生在发育过程中。这些变化可能对发育中的婴儿的适应很重要,了解它们的出现、调节和功能将有助于预测这些治疗方法在发育中的胎儿和婴儿接触肾上腺素能激动剂或拮抗剂时的治疗或毒性作用。